Opening the Ring of Cyclotides: The Cystine Knot Forms Even Without the Circular Backbone
Linear (ring-opened) versions of the cyclotide kalata B1 still fold into the characteristic cystine knot structure, but backbone cyclization is required for full biological activity and maximal stability.
Quick Facts
What This Study Found
Acyclic permutants of kalata B1 folded into native-like cystine knot structures without the circular backbone, but backbone cyclization was required for full biological activity and optimal structural stability.
Key Numbers
How They Did This
In-vitro structural study using synthetic linear versions of kalata B1. NMR spectroscopy determined structures, thermal stability measured, and biological activity compared to native cyclotide.
Why This Research Matters
For drug design, this means the cystine knot is a robust folding unit that could be used independently. But for maximum stability and activity, the full cyclic structure is needed.
The Bigger Picture
This study separates the contributions of the two structural features of cyclotides: the cystine knot provides the basic fold, while cyclization provides the extra stability and activity needed for function.
What This Study Doesn't Tell Us
Study on a single cyclotide (kalata B1). Other cyclotides may behave differently. Specific activity assays were limited.
Questions This Raises
- ?Can partially stabilized linear versions serve as simpler drug scaffolds?
- ?Does the cystine knot alone provide sufficient stability for oral drug delivery?
- ?Can cyclization be achieved more easily during synthesis?
Trust & Context
- Key Stat:
- Knot forms without ring The cystine knot folds correctly even in linear versions, but the circular backbone adds the stability and activity needed for drug function
- Evidence Grade:
- Moderate evidence from a well-designed structural comparison using NMR and functional assays on native and engineered cyclotide variants.
- Study Age:
- Published in 2000. This structure-function dissection has guided cyclotide drug engineering approaches.
- Original Title:
- Acyclic permutants of naturally occurring cyclic proteins. Characterization of cystine knot and beta-sheet formation in the macrocyclic polypeptide kalata B1.
- Published In:
- The Journal of biological chemistry, 275(25), 19068-75 (2000)
- Authors:
- Daly, N L(3), Craik, D J(3)
- Database ID:
- RPEP-00589
Evidence Hierarchy
Frequently Asked Questions
Can cyclotides work without being circular?
Partially. The 3D structure forms even when the ring is opened, but full biological activity and maximum stability require the complete circular backbone. Both features contribute to cyclotide function.
What does this mean for making cyclotide drugs?
It means drug designers can use the cystine knot as a folding scaffold even in linear peptides, but for the best therapeutic properties, maintaining the full cyclic structure is preferred.
Read More on RethinkPeptides
Cite This Study
https://rethinkpeptides.com/research/RPEP-00589APA
Daly, N L; Craik, D J. (2000). Acyclic permutants of naturally occurring cyclic proteins. Characterization of cystine knot and beta-sheet formation in the macrocyclic polypeptide kalata B1.. The Journal of biological chemistry, 275(25), 19068-75.
MLA
Daly, N L, et al. "Acyclic permutants of naturally occurring cyclic proteins. Characterization of cystine knot and beta-sheet formation in the macrocyclic polypeptide kalata B1.." The Journal of biological chemistry, 2000.
RethinkPeptides
RethinkPeptides Research Database. "Acyclic permutants of naturally occurring cyclic proteins. C..." RPEP-00589. Retrieved from https://rethinkpeptides.com/research/daly-2000-acyclic-permutants-of-naturally
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.